Next Generation Antidepressants

Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

Nonfiction, Health & Well Being, Medical, Specialties, Psychiatry, Ailments & Diseases, Mental Health
Cover of the book Next Generation Antidepressants by , Cambridge University Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781139833448
Publisher: Cambridge University Press Publication: May 20, 2010
Imprint: Cambridge University Press Language: English
Author:
ISBN: 9781139833448
Publisher: Cambridge University Press
Publication: May 20, 2010
Imprint: Cambridge University Press
Language: English

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

More books from Cambridge University Press

Cover of the book Civilising Globalisation by
Cover of the book Proactive Support of Labor by
Cover of the book The Biomedical Writer by
Cover of the book Rhetoric and Composition by
Cover of the book The Cambridge Companion to Duke Ellington by
Cover of the book Regulating Religion in Asia by
Cover of the book A Debt Against the Living by
Cover of the book A Farewell to Fragmentation by
Cover of the book Studying English Literature by
Cover of the book Human Dignity by
Cover of the book The Mortality and Morality of Nations by
Cover of the book Language in Immigrant America by
Cover of the book WTO Appellate Body Repertory of Reports and Awards by
Cover of the book Law, Justice, Democracy, and the Clash of Cultures by
Cover of the book Analysing Variation in English by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy